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At the midblastula transition during Xenopus development, the cell cycle is remodeled, and zygotic transcription is
initiated. Additionally, cyclin E1 is degraded at the midblastula transition independently of protein synthesis, the number
of cell cycles, and the nuclear-to-cytoplasmic ratio. In the studies reported here, cell cycles were delayed by transient
inhibition of protein synthesis with cycloheximide (100 mg/ml) prior to the midblastula transition. Even after reaccumula-
tion of mitotic cyclins and resumption of cell divisions, cycloheximide-treated embryos did not resume DNA synthesis,
failed to initiate transcription, and synchronously became apoptotic before the gastrula stage. These results were indepen-
dent of the stage at which embryos were treated or the duration of treatment. Inhibition of zygotic transcription with a-
amanitin also induced apoptosis. These data suggest that a developmental checkpoint at the midblastula transition is
maternally regulated and can trigger apoptosis. Apoptosis induced by cycloheximide or a-amanitin was blocked by injection
of RNA encoding Xenopus Bcl-2, suggesting that this maternal program is normally blocked by expression of an apoptotic
inhibitor. Embryos pulsed with lower doses of cycloheximide (10 mg/ml) delayed development prior to the midblastula
transition but resumed DNA synthesis, initiated transcription, and gastrulated normally. This indicates that the apoptotic
response is initiated only when delayed embryos are unable to support initiation of zygotic transcription.
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INTRODUCTION the ®rst 12 divisions and declines rapidly at the MBT (Har-
tley et al., 1996, 1997; Rempel et al., 1995). This disappear-
ance of cyclin E1 is independent of protein synthesis, theThe midblastula transition (MBT) in the development of
nuclear-to-cytoplasmic ratio (Howe and Newport, 1996),Xenopus begins between cleavage cycles 12 and 13 and is
and zygotic transcription (Hartley et al., 1997) but can becharacterized by cell-cycle lengthening and asynchrony, the
delayed by a speci®c inhibitor of cyclin E/Cdk2 (Hartley etacquisition of cell motility, and the initiation of zygotic
al., 1997). This suggests that cyclin E/Cdk2 complexes aretranscription (Newport and Kirschner, 1982a). Prior to the
an integral part of a maternal developmental timer thatMBT, embryonic development is relatively simple, con-
functions until the MBT, and disengagement of this timersisting of rapid cycles of DNA synthesis and mitosis, and
does not depend on initiation of the zygotic program.is regulated by mRNAs and proteins stored in the egg prior
In this report, we assess the consequences of uncouplingto fertilization. At the MBT, development becomes more
embryonic cleavage cycles from the maternal develop-complex as transcription initiates, the cell cycle lengthens,
mental timer. Cycloheximide was chosen as the uncouplingand cells differentiate and organize during gastrulation. Al-
agent as this reagent reversibly arrests cell division in thethough inhibition of zygotic transcription with a-amanitin
Xenopus embryo without evident toxicity (Cascio and Gur-blocks gastrulation (Newport and Kirschner, 1982a), some
don, 1987; Clute and Masui, 1995; Grainger and Gurdon,maternal transcripts persist after the MBT, suggesting that
1989). However, cycloheximide does not block oscillationsthe maternal program continues to regulate embryonic de-
of cyclin E/Cdk2 activity during early embryonic develop-velopment (Howe et al., 1995).
ment (Hartley et al., 1997) or degradation of cyclin E at theStudies of early cell cycles in Xenopus have further char-
MBT (Howe and Newport, 1996). Speci®cally, these studiesacterized the MBT. The level of cyclin E1 is constant during
were designed to address the following questions: (1) Is the
zygotic program (transcription) initiated when cyclin E deg-
radation occurs prior to the 12th cleavage? (2) What is the1 To whom correspondence should be addressed.
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taining Xenopus GS17 cDNA, provided by Dr. Paul Krieg, Univer-fate of embryos if they fail to initiate or maintain the zygotic
sity of Texas, Austin (Krieg and Melton, 1985), and pXenactin, aprogram?
plasmid containing 1 kb of Xenopus cardiac actin cDNA, which
was cloned from Stage 18 embryos by RT±PCR. The pXenactin
probe also reacts with cytoskeletal actin RNA in the pregastrulaMATERIALS AND METHODS embryo. 32P-labeled probes were generated using [a-32P]dCTP (Am-
ersham; 3000 Ci/mmole) and the Random Primed DNA Labeling
Maintenance and Manipulation of Embryos Kit (Boehringer Mannheim) according to the manufacturer's proto-
col. RNA blots were hybridized with 20 1 106 TCA-precipitable
Eggs from Xenopus laevis (wild-type or albino, Xenopus I, Ann
cpm/ml denatured probe in QuickHyb solution (Stratagene) and
Arbor, MI) were fertilized in vitro, dejellied in 2% cysteine, and
washed according to the manufacturer's protocol. Blots were ex-
maintained in 0.11 MMR (10 mM NaCl, 0.2 mM KCl, 0.1 mM
posed to Kodak XAR5 ®lm with an intensifying screen at 0807C.
MgSO4, 0.2 mM CaCl2, 0.5 mM Hepes, pH 7.8). Embryos were
staged according to Nieuwkoop and Faber (1975). At the indicated
stage (usually Stage 3, 7, or 9), embryos were incubated in Danil- Incorporation of [3H]Uridine into RNA orchik's medium (Peng, 1991) containing 0, 10, or 100 mg/ml cyclo-
[3H]Thymidine into DNAheximide (Calbiochem) or 500 mg/ml emetine (Sigma) for 15 min
or up to 2 hr. Embryos were then washed several times and main- Embryos were incubated in 200 mCi/ml [3H]uridine (35 Ci/
tained in 0.11 MMR. To inhibit transcription, a-amanitin (Sigma) mmole; ICN) in Danilchik's medium from 30 min postfertilization
in H2O was injected into one-cell embryos to an internal concentra- until Stage 7, when 100 mg/ml cycloheximide was added for 15 min
tion of 50 mg/ml, and embryos were maintained in 5% Ficoll in as described above. Ten treated embryos and sibling controls were
0.11 MMR. Control embryos were injected with an equal volume collected at Stages 7±10 and frozen on dry ice. Total RNA was
of H2O. For some experiments, embryos were injected at the one- isolated as described above, and the incorporation of [3H]uridine
cell stage with 10 ng RNA encoding FLAG-tagged Xenopus Bcl-2 into RNA was measured by scintillation counting of TCA-precipi-
in H2O and maintained in 5% Ficoll in 0.11 MMR. Control em- table material. Embryos were incubated in 900 mCi/ml [3H]-
bryos were injected with an equal volume of H2O. Xenopus bcl-2 thymidine (64 Ci/mmole; ICN) in Danilchik's medium from 30
cDNA, kindly provided by Dr. J. R. Tata (National Institute for min postfertilization until Stage 7, when cycloheximide was added
Medical Research, London, UK), was subcloned to be suitable for for 15 min as described above. Ten embryos were collected every
transcription. The RNA was transcribed and capped using the Am- 30 min and frozen on dry ice. To isolate DNA, embryos were lysed
bion mMessage mMachine kit. Embryos were ®xed in 4% para- as described by Newport and Kirschner (1982a), and nucleic acids
formaldehyde and photographed with a Wild Heerbrugg dissecting were extracted with phenol and phenol:chloroform (1:1), ethanol
microscope equipped with a 35-mm camera. precipitated, and resuspended in TE. The incorporation of [3H]-
thymidine into DNA was measured by scintillation counting of
TCA-precipitable material.
Immunoblotting of Embryonic Cyclins
Five embryos collected at the indicated times were frozen on dry
Assessment of Nuclear Morphologyice. To prepare extracts, embryos were homogenized in 50 ml EB
(Hartley et al., 1996) and centrifuged for 15 min at 47C. The super- Embryos treated with cycloheximide and sibling controls were
natants were diluted with sample buffer and boiled for 2 min. Ten ®xed in 4% paraformaldehyde, dehydrated through an ethanol se-
microliters of each sample was electrophoresed on 12.5% acryl- ries, cleared in xylenes, embedded in paraf®n, sectioned 7 mm thick,
amide gels and transferred to nitrocellulose with a Pharmacia semi- deparaf®nized with xylenes, rehydrated through an ethanol series,
dry transfer apparatus. The immunoblots were blocked for nonspe- and stained with 1 mg/ml DAPI. Serial sections were viewed and
ci®c reactivity in 10% nonfat dry milk in PBS at room temperature photographed by phase-contrast and ¯uorescence microscopy on a
for 2 hr, reacted with af®nity-puri®ed polyclonal antibodies against Leitz Dialux 20 microscope equipped with a 35-mm camera.
Xenopus cyclin A1 (Gautier et al., 1990), cyclin B1 (Rempel et al.,
1995), and cyclin E1 (Rempel et al., 1995) in 10% nonfat dry milk
in PBS at 47C overnight, washed in PBS containing 0.05% Tween Electron Microscopy
20, incubated with peroxidase-conjugated secondary antibodies
Embryos treated with 100 mg/ml cycloheximide for 15 min at(1:5000) in 10% nonfat dry milk in PBS for 1 to 2 hr, and washed
Stage 9 and sibling controls were collected when development ap-in PBS containing 0.05% Tween 20. Cyclins were visualized by
peared abnormal and ®xed in 2% buffered glutaraldehyde at 47Cchemiluminescence with the Amersham ECL kit.
overnight. Embryos were then sectioned and processed for routine
transmission electron microscopy.
Northern Analysis of Embryonic RNA
Total RNA was isolated from embryos using TriReagent (Molec- Whole-Mount TUNEL Assays
ular Research Center Inc.) according to the manufacturer's protocol
and treated with RQ DNase (Promega) in the presence of RNasin TUNEL (TdT-mediated dUTP-X nick end labeling) assays to de-
tect double-stranded breaks in DNA were performed using a modi-(Promega). Ten micrograms of each RNA sample was resolved by
electrophoresis on a 1% Mops denaturing agarose gel and trans- ®ed version of the protocol developed by Gert Jan C. Veenstra (Hu-
brecht Laboratory, Utrecht, The Netherlands). Albino embryosferred to a Nytran membrane with a TurboBlotter apparatus
(Schleicher & Schuell). RNA was then cross-linked to the mem- treated with cycloheximide or a-amanitin as described above were
collected (with or without vitelline membranes) when develop-brane with a Stratagene UV crosslinker. Random-primed probes
were synthesized using inserts from pSP64GS17, a plasmid con- ment appeared abnormal and controls were gastrulating. Embryos
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were ®xed 1 to 2 hr in MEMFA (100 mM Mops, pH 7.4, 2 mM
EGTA, 1 mM MgSO4, 3.7% formaldehyde), dehydrated in ethanol,
and stored in ethanol at0207C overnight. Embryos were then rehy-
drated through an ethanol series, washed sequentially in PBS,
PTween (PBS containing 0.2% Tween 20), PBS, and TdT buffer
(Gibco BRL). Embryos were then incubated overnight at room tem-
perature in TdT buffer containing 150 U/ml terminal deoxynucleoti-
dyl transferase (TdT; Gibco BRL) and 0.5 mM digoxygenin±dUTP
(Boehringer Mannheim). The next day, embryos were washed twice
for 1 hr at 657C with PBS containing 1 mM EDTA, four times for
1 hr with PBS at room temperature, once for 15 min with PBT (PBS
containing 2 mg/ml BSA and 0.1% Triton X-100), and once for 1
hr or more with PBT containing 20% normal goat serum. Embryos
were then incubated overnight at 47C in PBT containing 20% nor-
mal goat serum and alkaline phosphatase-conjugated anti-digoxy-
genin Fab fragments (1:2000; Boehringer Mannheim). Embryos were
washed for 24 hr with multiple changes of PBT and then brie¯y
with alkaline phosphatase buffer (100 mM Tris, pH 9.5, 50 mM
MgCl2, 100 mM NaCl, 0.1% Tween 20, 5 mM levamisol). The
chromagenic reaction was performed in alkaline phosphatase buffer
containing 0.33 mg/ml NBT and 0.175 mg/ml BCIP (Boehringer
Mannheim). When reactions reached the desired intensity, embryos
were washed in alkaline phosphatase buffer, re®xed in MEMFA for
3 hr, and stored in 70% ethanol.
Isolation of Genomic DNA
Embryos were homogenized in DNA extraction buffer (10 mM
Tris, pH 8.0, 0.1 mM EDTA, 50 mg/ml RNase A, 0.5% SDS) and
incubated at 377C for 1 hr. Proteinase K was added to a ®nal concen-
tration of 100 mg/ml, and samples were incubated at 507C for 2 hr.
Samples were extracted sequentially with phenol and phenol:chlo-
roform (1:1), and the DNA was precipitated with ethanol. Total
FIG. 1. Embryos pulsed with high doses of cycloheximide at Stagegenomic DNA was resolved by electrophoresis on a 2% agarose gel
7 develop abnormally after the MBT. Embryos were treated withand visualized by staining with ethidium bromide.
0 (A, D, G, J) 10 (B, E, H, K), or 100 (C, F, I, L) mg/ml cycloheximide
for 15 min at Stage 7 and collected when control embryos reached
Stage 8 (A, B, C), 9 (D, E, F), 10 (G, H, I), or 24 hr postfertilization
RESULTS (J, K, L). Scale bar, 500 mm.
Embryos Pulsed with High Doses of Cycloheximide
Develop Abnormally after the Midblastula pulsed with 10 mg/ml cycloheximide, although delayed,
Transition appeared normal relative to controls, and many of these
embryos survived beyond 24 hr postfertilization (Fig. 1K).The increase in nuclear/cytoplasmic ratio during cleav-
Similar results were observed with embryos treated atage depends on alternating cycles of DNA synthesis and
Stages 3 or 5 (not shown), indicating that the effect ofcyclin B synthesis (Hartley et al., 1996; Murray and
cycloheximide was independent of the timing of adminis-Kirschner, 1989). Therefore, to delay cleavage divisions,
tration. These studies indicate that treatment with cyclo-embryos were pulsed at Stage 7 for 15 min with 10 or 100
heximide prior to the MBT reversibly arrests cell divi-mg/ml cycloheximide, an inhibitor of protein synthesis.
sions in embryos. The delay induced by lower doses ofThe embryos were then returned to 0.11MMR, and devel-
cycloheximide did not induce developmental defectsopment was monitored (Fig. 1). Embryos treated with ei-
prior to gastrulation, whereas the longer delay inducedther dose of cycloheximide resumed cell divisions upon
by the higher dose led to abnormal development, failureremoval of the treatment. Those pulsed with the lower
to gastrulate, and death. Most interestingly, the effectsdose were usually one division behind controls by the
of perturbing development prior to the MBT were notMBT, whereas those pulsed with the higher dose were
manifest until after the MBT.delayed further (two or more cell divisions). All embryos
continued to divide beyond 5 hr postfertilization, the be-
Cyclins Reaccumulate in Embryos Pulsed withginning of the MBT in control embryos. After this time,
Cycloheximideembryos pulsed with 100 mg/ml cycloheximide appeared
abnormal, did not gastrulate (Fig. 1I), and died within 24 The resumption of cleavage in embryos after withdrawal
of cycloheximide suggested that mitotic cyclins had reaccu-hr (Fig. 1L). On the other hand, gastrulation in embryos
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does not ¯uctuate in normal embryos prior to the MBT
(Hartley et al., 1996; Rempel et al., 1995), was unaffected
by transient treatment with cycloheximide (Fig. 2). This
®nding further supports the idea that cyclin E1 is an integral
part of a maternal developmental timer that functions inde-
pendently of protein synthesis (Hartley et al., 1997; Howe
and Newport, 1996).
Cycloheximide Treatment Does Not Affect the
Time of Disappearance of Cyclin E1
The time postfertilization of the degradation of cyclin E1
is unaltered in embryos maintained continuously in 100
mg/ml cycloheximide, further supporting a role for cyclin
E1 in the developmental timer (Howe and Newport, 1996)
and suggesting that the disappearance of cyclin E1 may
mark a ®xed time for the initiation of the MBT. However,
this disappearance is delayed when mitotic cell cycles are
slowed in the presence of a speci®c inhibitor of cyclin E/
Cdk2 activity (Hartley et al., 1997). To determine whether
slowing of embryonic cycles by transient treatment with
cycloheximide also delayed the disappearance of cyclin E1,
embryos were pulsed with 10 or 100 mg/ml cycloheximide
for 15 min at Stage 7 and monitored for the disappearance
FIG. 2. Mitotic cyclins reaccumulate in embryos pulsed with
of cyclin E1 (Fig. 3). There were no reproducible differencescycloheximide. Embryos were pulsed with 10 or 100 mg/ml cyclo-
in the timing of cyclin E disappearance regardless of theheximide (CHX) for 15 min at Stage 3 (1:45 postfertilization) and
dose of cycloheximide, the stage at which embryos werecollected with sibling controls at timed intervals during and after
treated, or the duration of treatment (data not shown). Thus,the treatment. Immunoblots generated from these embryos and
the timing of cyclin E1 degradation is not perturbed by tran-reacted with antibodies against cyclins A1, B1, and E1 are shown.
sient inhibition of protein synthesis, and this event marks
the beginning of the MBT both in control and cyclohexi-
mide-treated embryos.
mulated to suf®cient levels to drive cell division. To di-
rectly examine the effect of cycloheximide on the levels of
embryonic cyclins, control embryos and siblings treated
with 10 or 100 mg/ml cycloheximide for 15 min at Stage 3
were collected periodically during the drug treatment and
after its removal. Immunoblots revealed that the levels of
cyclins A1 and B1 were reduced in the presence of 100 mg/
ml cycloheximide, but these proteins reaccumulated upon
removal of the drug (Fig. 2). The inhibition of cyclin A and
B synthesis by the lower dose of cycloheximide (10 mg/ml)
was subtle, but the lengthened periodicity of cyclin A and
B expression in the second cycle was consistent with the
resumption of slower cell divisions in these embryos and
with the synthesis and degradation of the mitotic cyclins
during each cell cycle (Hartley et al., 1996). Most likely,
the delay was not observed until the second cycle because
either mitotic cyclins had accumulated to threshold levels
prior to drug administration or more time was required for
effective concentrations of cycloheximide to be taken up
by the embryos. Inhibition of cyclin A and B synthesis by
the higher dose of cycloheximide (100 mg/ml) approached
100% during the ®rst cycle and persisted much longer, with FIG. 3. Cyclin E disappears at the normal time in cycloheximide-
approximately 1 hr required for detectable reaccumulation. treated embryos. Embryos treated with 0, 10, or 100 mg/ml cyclo-
The reappearance of mitotic cyclins after removal of cyclo- heximide (CHX) for 15 min at Stage 7 were collected every 30 min
heximide con®rmed the reversibility of inhibition of pro- for 3 hr. An immunoblot generated from these embryos and reacted
with an antibody against cyclin E1 is shown.tein synthesis. In contrast, the level of cyclin E1, which
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heximide, the accumulation of GS17 RNA at the MBT was
delayed, consistent with a delay in development. However,
embryos treated with 100 mg/ml cycloheximide failed to
express GS17 (Fig. 4A). Likewise, GS17 RNA was barely
detectable in embryos pulsed with 100 mg/ml cyclohexi-
mide for 15 min at Stage 7 and collected at Stages 9, 10,
and 10.5 (data not shown). Therefore, a brief pulse with a
high dose of cycloheximide prior to the MBT inhibits the
accumulation of gastrula-speci®c transcripts. Initiation of
transcription depends upon a critical nuclear-to-cyto-
plasmic ratio (Newport and Kirschner, 1982b), and these
results are consistent with failure to achieve that ratio in
cycloheximide-treated embryos which are delayed by two
or more cleavage cycles at the time control embryos begin
the MBT.
It was possible, however, that expression of a particular
subset of genes, including GS17, was particularly sensitive
to cycloheximide and not an accurate measure of global
zygotic transcription. Therefore, to determine the effect of
high doses of cycloheximide on total zygotic transcription,
embryos were loaded with [3H]uridine from 30 min postfer-
tilization until Stage 7, when 100 mg/ml cycloheximide was
added for 15 min. Ten embryos were collected at Stages 7,
8, 9, and 10 and analyzed for incorporation of isotope into
RNA as a measure of de novo transcription (Fig. 4B). There
was no transcription in the cycloheximide-treated embryos,
whereas the control embryos incorporated [3H]uridine into
RNA, consistent with activation of zygotic transcription at
the MBT. Thus, a 15-min pulse of 100 mg/ml cycloheximide
prior to the MBT, even as early as Stage 3, completely blocks
new transcription at the MBT.FIG. 4. Zygotic transcription is altered in embryos pulsed with
cycloheximide prior to the MBT. (A) Accumulation of gastrula-
speci®c transcripts is altered in embryos pulsed with cyclohexi-
mide prior to the MBT. Embryos were treated with 0, 10, or 100 DNA Replication Is Inhibited in Embryos Pulsed
mg/ml cycloheximide (CHX) for 15 min at Stage 3. A Northern blot with Cycloheximide
of total RNA isolated from these embryos is shown. The blot was
probed for GS17, stripped, and reprobed for cytoskeletal actin, a Before the initiation of zygotic transcription, embryonic
maternal transcript. (B) Transcription is completely blocked in em- development consists of rapid cycles of DNA replication
bryos pulsed with cycloheximide prior to the MBT. Embryos were and mitosis. Since embryos pulsed with 100 mg/ml cyclo-
loaded with [3H]uridine prior to treatment with 0 or 100 mg/ml heximide prior to the MBT developed abnormally and failed
cycloheximide for 15 min at Stage 7. Embryos were collected at
to transcribe the zygotic genome despite a reaccumulationStages 7±10 and analyzed for incorporation of isotope into RNA.
of mitotic cyclins and resumption of cleavages, it is likelyCPM, radioactive counts per minute.
that cycloheximide treatment perturbed another phase of
the cell cycle, such as DNA synthesis. To investigate this,
embryos were loaded with [3H]thymidine prior to treatment
with cycloheximide for 15 min at Stage 7, and the incorpora-Zygotic Transcription Is Inhibited in Embryos
tion of [3H]thymidine into DNA was determined from thePulsed with Cycloheximide Prior to the MBT
time of treatment until 7 hr postfertilization (Fig. 5). DNA
replication was transiently delayed in embryos pulsed withSince the development of cycloheximide-pulsed embryos
appeared abnormal after the MBT regardless of the time of 10 mg/ml cycloheximide, resulting in two- to fourfold de-
creased incorporation of thymidine at the MBT. DNA repli-protein synthesis inhibition, it seemed possible that normal
initiation of zygotic transcription at the MBT was per- cation was completely inhibited in embryos treated with
100 mg/ml cycloheximide. Therefore, at the time siblingturbed. To directly examine this, embryos were pulsed with
cycloheximide and collected with sibling controls at Stages control embryos reached the MBT, embryos that had been
treated with 100 mg/ml cycloheximide at Stage 7 had only7 through 10.5. Total RNA isolated from these embryos was
probed by Northern blotting for GS17, a gastrula-speci®c a Stage 7 content of DNA and had not attained the normal
nuclear/cytoplasmic ratio before the disappearance of ma-transcript (Krieg and Melton, 1985). When embryos were
treated at Stage 3 (Fig. 4A) for 15 min with 10 mg/ml cyclo- ternal cyclin E1. Similar results were obtained when em-
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pared to controls (Fig. 6C) consistent with inhibited DNA
replication after the cycloheximide pulse (Fig. 5). At higher
magni®cation, the nuclei in the cycloheximide-pulsed em-
bryos looked abnormal (Figs. 6F and 6H). The DNA appeared
lacy and damaged, consistent with abnormal mitoses (Fig.
6F), or as condensed masses of chromatin resembling apop-
totic bodies within the nucleus (Fig. 6H; Kerr et al., 1994).
No apoptotic nuclei were observed in the control embryos
(Figs. 6E and 6G), and many mitotic ®gures were found (Fig.
6E). These data suggest that the death of embryos treated
with cycloheximide is due to apoptosis. Cycloheximide-
pulsed embryos examined prior to the MBT contained chro-
matin that appeared damaged (like the nuclei shown in Fig.
6F) without apoptotic bodies, suggesting that apoptosis does
not occur before the MBT (data not shown).
FIG. 5. DNA replication is perturbed in embryos pulsed with To determine whether the induction of apoptosis by
cycloheximide. Embryos loaded with [3H]thymidine and pulsed
with 0, 10, or 100 mg/ml cycloheximide for 15 min at Stage 7 were
used to assay [3H]thymidine incorporation into DNA. CHX, cyclo-
heximide; CPM, radioactive counts per minute.
bryos were pulsed with cycloheximide at Stage 3 (data not
shown).
These data are consistent with reports that cleavage cy-
cles occur normally until the MBT when DNA replication
is inhibited by aphidicolin (Newport and Dasso, 1989). The
irreversible arrest of DNA synthesis by pulses with high
doses of cycloheximide explains the failure to detect zygotic
transcription in these embryos. Either transcription was ini-
tiated but was too low to detect due to the decreased content
of DNA at the MBT or it was never triggered because the
embryos had not reached an appropriate nuclear/cyto-
plasmic ratio. The latter explanation is favored since em-
bryos treated at Stage 7 had only fourfold less DNA at the
MBT than controls, yet no accumulation of incorporated
[3H]uridine was detectable even after transcription had pro-
ceeded for 5 hr in sibling controls (Stage 10; Fig. 4B).
Apoptosis Occurs in Embryos Pulsed with High
Doses of Cycloheximide
Embryos that failed to replicate DNA, developed abnor-
mally, and died after cycloheximide treatment resembled
those that become apoptotic in response to DNA-damaging
agents (Anderson et al., 1997). To determine whether
apoptosis occurred in the cycloheximide-treated embryos,
nuclear morphology was examined. Embryos treated with
FIG. 6. Apoptosis occurs in embryos pulsed with cycloheximide100 mg/ml cycloheximide for 15 min at Stage 7 were col-
at Stage 7. Embryos that were pulsed with 100 mg/ml cycloheximidelected when the embryos appeared abnormal and the sibling
for 15 min at Stage 7 were collected along with sibling controlscontrols were gastrulating. Histologic sections of these em-
when their development appeared abnormal and controls gastru-bryos were stained with DAPI (Fig. 6). Phase-contrast mi-
lated. Histologic sections of embryos stained with DAPI are shown.
croscopy at low magni®cation demonstrated that cyclohexi- A, C, E, G, controls; B, D, F, H, cycloheximide treated; A, B, phase;
mide-treated embryos contained fewer and larger cells (Fig. C±H, ¯uorescence; scale bars, 100 mm (A±D), 10 mm (E±H); arrow-
6B) than control embryos (Fig. 6A), con®rming gross mor- heads, a mitotic ®gure in a single cell in a control embryo; open
phological observations (Fig. 1). Fluorescence microscopy arrows, abnormal chromatin in treated embryos; ®lled arrow, apop-
totic bodies.revealed weak staining of nuclei with DAPI (Fig. 6D) com-
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FIG. 7. Apoptosis is observed in embryos treated with emetine or cycloheximide. Embryos treated with 100 mg/ml cycloheximide (B) or
500 mg/ml emetine (C) for 15 min at Stage 7 were collected with sibling controls (A) when their development appeared abnormal and
controls gastrulated. Embryos pulsed with 100 mg/ml cycloheximide (D, F) for 30 min at Stage 9 were collected with sibling controls (E)
when their development appeared abnormal and controls gastrulated. Histologic sections of embryos stained with DAPI are shown. Scale
bars, 10 mm (A±C, E, F); 100 mm (D); arrows, apoptotic bodies; arrowheads, blastocoel ®lled with detached, apoptotic cells.
highdoses of cycloheximide truly resulted from inhibition
of protein synthesis rather than from a particular toxicity
of this drug, embryos were pulsed at Stage 7 for 15 min with
500 mg/ml emetine, another inhibitor of protein synthesis.
Emetine induced abnormal development and the appear-
ance of apoptotic bodies with a similar time course as cyclo-
heximide (Compare Figs. 7B and 7C). This suggests that
interference with protein synthesis prior to the MBT spe-
ci®cally triggers apoptosis in Xenopus embryos.
Since DNA synthesis was inhibited in embryos treated
at Stage 7 with a high dose of cycloheximide, the content
of DNA available for histologic observations of these em-
bryos was limited. In order to increase the amount of DNA
available for study, embryos were treated with a high dose
of cycloheximide for 30 min at Stage 9, three cell cycles
later. These embryos arrested cleavage at Stage 9 and con-
tained many apoptotic bodies when development appeared
abnormal (Fig. 7F). Furthermore, in these embryos, detached
cells that appeared apoptotic accumulated in the blastocoel
(Fig. 7D), a phenomenon also observed in embryos that be-
come apoptotic in response to DNA-damaging agents (An-
derson et al., 1997). Likewise, embryos pulsed with the high
dose of cycloheximide at Stages 10.5 or 11 also arrested
cleavage and accumulated apoptotic nuclei (data not
shown). Since cycloheximide treatment after the MBT had
no measurable effect on zygotic transcription (data not FIG. 8. Electron microscopy reveals hallmarks of apoptosis, not
shown), we attribute the induction of apoptosis after the necrosis, in cycloheximide-treated embryos. Thin section of a cell
MBT more directly to the inhibition of protein translation. from an embryo treated at Stage 9. Scale bar, 10 mm; N, nucleus; C,
These data indicate that the apoptotic program is main- cytoplasm; Y, yolk platelet; arrows, apoptotic bodies; arrowheads,
nuclear membrane.tained in pregastrula and gastrula embryos.
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FIG. 9. Inhibition of protein synthesis induces a strong positive TUNEL reaction in embryos. Albino Xenopus embryos were treated
with 100 mg/ml cycloheximide (B) or 500 mg/ml emetine (C) for 15 min at Stage 7 and collected when controls (A) were gastrulating.
TUNEL-reactive cells are located at the animal pole. Scale bar, 500 mm.
To further characterize the death of cycloheximide- An additional marker for apoptosis is the cleavage of ge-
treated embryos, and speci®cally to distinguish between nomic DNA into 180-bp internucleosomal fragments. One
apoptosis and necrosis (Kerr et al., 1994), thin sections of method of visualizing these fragments is the TUNEL assay,
cycloheximide-treated embryos were analyzed by electron which labels double-stranded DNA breaks. Whole-mount
microscopy (EM) to determine whether cells from cyclohex- TUNEL assays were performed on albino embryos that had
imide-treated embryos possessed the classic features of been treated for 15 min at Stage 7 with 100 mg/ml cyclohexi-
apoptosis. The condensed masses of chromatin detected by mide or 500 mg/ml emetine and collected when develop-
¯uorescent light microscopy (Fig. 7F) were observed by EM ment appeared abnormal and controls were gastrulating
to be within a nucleus with an intact nuclear membrane (Fig. 9). A strong positive TUNEL reaction was detected in
(Fig. 8). Other organelles appeared normal, with no evidence cells clustered around the animal pole in embryos treated
of swelling or lysis (Fig. 8). These data are diagnostic of an with cycloheximide (Fig. 9B) or emetine (Fig. 9C). Embryos
apoptotic rather than a necrotic cell death (Kerr et al., 1994). treated with the high dose of cycloheximide for 30 min at
Stage 9 gave a similar TUNEL reaction (data not shown), and
labeled cells were also detected in the blastocoel, consistent
with the histological data (Fig. 7D). The TUNEL assay pro-
vides a quantitative estimate for the extent of apoptosis in
these embryos. However, many cells lost their intercellular
attachments when treated with cycloheximide or emetine
and these cells were lost in the processing of embryos for
the TUNEL assay. Thus, it is likely that the percentage of
apoptotic cells was signi®cantly higher than indicated by
the TUNEL assay.
The cleavage of DNA into internucleosomal fragments
can also be detected as 180-bp DNA ladders on an agarose
gel (Wyllie et al., 1980). To determine whether cyclohexi-
mide treatment of embryos generated DNA fragmenta-
tion characteristic of apoptosis, genomic DNA was iso-
lated from embryos pulsed with cycloheximide for 30 min
at Stage 9 (Fig. 10A). This DNA resolved into 180-bp lad-
ders in cycloheximide-treated but not in control embryos,
consistent with the strong positive TUNEL reactions. An-
FIG. 10. Cycloheximide and a-amanitin induce internucleosomal other hallmark of apoptosis is its inhibition by the prod-
fragmentation of genomic DNA. (A) Embryos were injected at the uct of the bcl-2 gene (Reed, 1994). To determine whether
one-cell stage with 5 ng bcl-2 RNA or an equal volume of H2O, Bcl-2 could block the induction of apoptosis by cyclohexi-
treated for 30 min at Stage 9 with 100 mg/ml cycloheximide (CHX), mide, embryos were microinjected at the one-cell stage
and collected when controls were gastrulating. Genomic DNA with 10 ng RNA encoding FLAG-tagged Xenopus Bcl-2
from approximately 30 embryos was isolated and resolved on a 2%
(Cruz-Reyes and Tata, 1995) and then treated with cyclo-agarose gel. (B) Embryos were injected with or without 5 ng bcl-2
heximide for 30 min at Stage 9. In control experiments,RNA and 50 ng a-amanitin and collected when controls gastru-
FLAG-tagged Bcl-2 was detected with an anti-FLAG anti-lated. Genomic DNA from approximately 50 embryos was resolved
on a 2% agarose gel. body by Stage 4 (data not shown). Bcl-2 RNA had no de-
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FIG. 11. a-Amanitin induces a strong positive TUNEL reaction in embryos. Albino Xenopus embryos were injected with 50 ng a-
amanitin (B, C) or H2O (A) at the one-cell stage and collected when controls were gastrulating. TUNEL-reactive cells are located at the
animal pole (B) and are absent from the vegetal pole (C). Scale bar, 500 mm.
tectable effect on development prior to the MBT but in- DISCUSSION
hibited the accumulation of DNA ladders in response to
cycloheximide (Fig. 10A). The classic de®nition of the midblastula transition has
Since apoptosis was observed in cycloheximide-treated been modi®ed by studies that demonstrate maternal control
embryos that failed to initiate zygotic transcription, the of development after the MBT (Newport and Kirschner,
apoptotic program must be maternally controlled. Hall- 1982a) and by the discovery that some MBT events are inde-
marks of apoptosis were not observed until sibling controls pendent of one another (Clute and Masui, 1995; Hartley et
were gastrulating, regardless of the time of the cyclohexi- al., 1997; Yusada and Schubiger, 1992). These data imply
mide pulse. This suggests that apoptosis does not occur that the MBT is truly a transition and not simply a switch
until after the MBT, as measured by the timing of degrada- from one regulatory program to another. The only MBT
tion of maternal cyclin E1. events known to occur at a ®xed time after fertilization are
the degradation of maternal cyclins E1 and A1 (Hartley et
al., 1997; Howe et al., 1995; Howe and Newport, 1996) and
the appearance of microtubule-dependent nuclear cell cy-Inhibition of Transcription at the MBT Induces
cles (Clute and Masui, 1995). Other events associated withApoptosis
the MBT, such as cell motility and zygotic transcription,
may be regulated by the nuclear/cytoplasmic ratio as origi-The studies shown above indicate that zygotic transcrip-
tion is inhibited and apoptosis activated after the MBT by nally postulated (Newport and Kirschner, 1982a) or, more
speci®cally, by titration of repressing factors (Prioleau et al.,transient inhibition of protein synthesis with cyclohexi-
mide. To investigate whether these two events are directly 1994). In the studies described here, pulses of cycloheximide
during pregastrula development inhibited DNA synthesisrelated, embryos were microinjected at the one-cell stage
with a-amanitin, an inhibitor of RNA polymerase. Total and slowed cleavage cycles, but the cyclin E degradation
program was unaffected. The result was complete inhibi-RNA was collected for Northern analysis of GS17 expres-
sion when controls were gastrulating. GS17 RNA was de- tion of zygotic transcription and activation of an apoptotic
program. This effect was observed regardless of the timingtected in sibling controls but not in treated embryos, indi-
cating that transcription was inhibited (data not shown). or duration of the cycloheximide pulse. Prevention of tran-
scription directly with a-amanitin also induced apoptosisDNA was isolated from these embryos and assayed for inter-
nucleosomal cleavage as a marker of apoptosis (Fig. 10B). after the MBT. These results extend the de®nition of the
MBT and suggest that it marks expression of a maternalDNA ladders of 180 bp were detected in embryos treated
with a-amanitin, indicating that inhibition of transcription program of apoptosis that requires zygotic transcription to
block its engagement.triggered an apoptotic program. Furthermore, as for cyclo-
heximide, induction of apoptosis by a-amanitin was inhib- The complete inhibition of zygotic transcription by 15-
min pulses with the high dose of cycloheximide is consis-ited by bcl-2 RNA (Fig. 10B). a-Amanitin also induced a
strong positive TUNEL reaction (Fig. 11), consistent with tent with the irreversible inhibition of DNA replication by
this treatment. Xenopus embryos injected with cyclohexi-the DNA laddering data (Fig. 10B). These studies support
the hypothesis that a maternal program of apoptosis is acti- mide complete one additional round of DNA synthesis be-
fore arresting prior to mitosis in a G2-like state (Miake-Lyevated if zygotic transcription is not initiated at the MBT.
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et al., 1983). Since cycloheximide-treated embryos replicate during which many cell cycle checkpoints occur. That these
early cycles occur independently of DNA content (Newportbut never rereplicate injected exogenous DNA (Harland and
Laskey, 1980), this arrest of the nuclear cell cycle is not and Dasso, 1989) or quality is testimony to their autonomy
and evident lack of checkpoints. Thus, the MBT may bedue to inactivation of the DNA replication machinery. The
oscillatory cell cycle resumes until the MBT, indicating that the ®rst checkpoint that monitors developmental progres-
sion in early embryos. It is likely that this checkpoint moni-it is reversibly sensitive to inhibition of cyclin synthesis and
separable from the nuclear cell cycle as previously shown tors DNA content and/or quality since apoptosis is also
induced by aphidicolin, an inhibitor of DNA polymerase a(Howe and Newport, 1996; Hartley et al., 1997).
Based on these considerations, embryos pulsed with 100 (J. Sible, unpublished data) and gamma irradiation, which
damages DNA (Anderson et al., 1997). Surprisingly, thismg/ml cycloheximide may fail to initiate zygotic transcrip-
tion because they do not reach the correct nuclear/cyto- checkpoint is maternally controlled. It will be interesting
to determine whether embryos also exhibit cell cycle arrestplasmic ratio at a ®xed time. Cycloheximide treatment is
not known to inhibit transcription directly and, in many (Paulovich et al., 1997) at the apoptotic checkpoint since it
has been suggested that these two events may be linkedcases, has been shown to activate the expression of certain
genes (Elder et al., 1984; Forsdyke, 1984; Ishihara et al., (Evan et al., 1995; King and Cidlowski, 1995; Meikrantz and
Schlegel, 1995).1984; Makino et al., 1984), arguing against a nonspeci®c
inhibition of transcription by this drug. Embryos in which Although delayed, embryos pulsed with the lower dose
of cycloheximide initiate transcription and gastrulate nor-cyclin B mRNA has been depleted with anti-sense oligonu-
cleotides also transiently arrest, then resume both nuclear mally, suggesting that there is some tolerance in the timing
of this developmental checkpoint. These embryos were gen-and cytoplasmic cycles, but fail to activate the zygotic pro-
gram and never gastrulate (Weeks et al., 1991). These em- erally one cell cycle behind sibling controls when the latter
began the MBT. Likewise, division asynchrony normallybryos may also fail to reach the appropriate nuclear/cyto-
plasmic ratio before the MBT time as marked by the disap- occurs at cycle 13 but will occur at cycle 14 in particularly
large eggs or those that have been pulsed with 14 mg/mlpearance of maternal cyclin E1.
The treatment of embryos with 100 mg/ml cycloheximide cycloheximide (Clute and Masui, 1995). Thus, embryos
treated with 10 mg/ml cycloheximide may be delayed oror more direct inhibition of transcription with a-amanitin
led to apoptosis after the MBT. An apoptotic program that damaged but reparable within one division cycle, whereas
embryos treated with 100 mg/ml cycloheximide to com-responds to developmental abnormalities has been de-
scribed in Drosophila (White et al., 1994) and mouse (Pierce pletely arrest DNA replication are too compromised, and
apoptosis results.et al., 1989) embryos, and nuclear events consistent with
apoptosis have been characterized in Xenopus cell-free ex- It is important to consider why Xenopus embryos possess
this apoptotic program and whether it is designed to elimi-tracts (Newmeyer et al., 1994). The concept of the MBT as
the ®rst apoptotic checkpoint is supported by the observa- nate an entire embryo (global apoptosis) or to remove indi-
vidual, damaged cells within the embryo (cellulartion that death was never observed in these embryos before
the MBT, although it cannot be excluded that this re¯ects apoptosis). We favor the latter possibility since we never
observed apoptosis in every cell of the embryo as deter-the amount of time required for an apoptotic program to be
enacted. It is clear that like the degradation of cyclin E, this mined by TUNEL assays and histology, and we did detect
sporadic apoptotic cells in untreated embryos. Therefore,apoptotic program is maternally driven. Thus, it is likely
that the apoptotic machinery is in place in early embryos we suggest that an apoptotic program is engaged by individ-
ual cells, and provided there are few damaged cells, theirand zygotic expression of an inhibitor after the MBT is re-
quired to prevent its engagement. removal will result in normal embryonic development.
Treatment of embryos with cycloheximide or a-amanitinIndeed, induction of apoptosis by cycloheximide in vivo
and in vitro (Bansal et al., 1991; Collins et al., 1991; Ledda- presents such an assault that apoptosis is triggered in
enough cells to render the embryo inviable.Columbano et al., 1992; Martin et al., 1990) is usually inter-
preted as the loss of an inhibitor of apoptosis. Since pulses In summary, our results support the concept that the
MBT consists of several separable events rather than a sin-with 100 mg/ml cycloheximide before the MBT completely
blocked new transcription, the expression of an apoptotic gle developmental switch (Yusada and Schubiger, 1992).
One of these events is a maternal checkpoint that inducesinhibitor may have been compromised. Bcl-2, an inhibitor
of apoptosis, is expressed after the MBT (Cruz-Reyes and an apoptotic program in developmentally compromised
Xenopus embryos.Tata, 1995) and is shown here to be suf®cient to delay or
block apoptosis induced by cycloheximide or a-amanitin.
Therefore, transcription of bcl-2 could be the develop-
mental switch that determines continued development ver- ACKNOWLEDGMENTS
sus apoptosis.
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